Baricitinib and tofacitinib off-target profile, with a focus on Alzheimer's disease.
Faquetti ML, Slappendel L, Bigonne H, Grisoni F, Schneider P, Aichinger G, Schneider G, Sturla SJ, Burden AM.
Faquetti ML, et al. Among authors: burden am.
Alzheimers Dement (N Y). 2024 Jan 26;10(1):e12445. doi: 10.1002/trc2.12445. eCollection 2024 Jan-Mar.
Alzheimers Dement (N Y). 2024.
PMID: 38528988
Free PMC article.